Li et al found that exenatide and liraglutide inhibited proliferation and induced apoptosis in LNCap.[31] As we mentioned earlier, Nomiyama et al found that exendin-4, as 1 of GLP-1 receptor agonists reduced tumor volume primarily by affecting LNCap cells.[11]. This evidence concerns the gene GLP1R and neoplasm.